Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Drugs & Aging

Issue 1/2009

Content (7 Articles)

Review Article

Complexities of Diagnosis and Treatment of Allergic Respiratory Disease in the Elderly

Paula J. Busse, Kiran Kilaru

Review Article

Black Cohosh for the Management of Menopausal Symptoms

Carlos Palacio, Ghania Masri, Arshag D. Mooradian

Review Article

Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes

Charlotte L. R. Verrue, Mirko Petrovic, Els Mehuys, Jean Paul Remon, Robert Vander Stichele

Original Research Article

Self-Medication in Older Urban Mexicans

Fernando Ruiz Balbuena, Alfredo Briones Aranda, Albert Figueras

Original Research Article

Olmesartan Medoxomil in Elderly Patients with Essential or Isolated Systolic Hypertension

Anthony M. Heagerty, Jean-Michel Mallion

Original Research Article

Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium

Avi Levin, Moshe Ben-Artzi, Pazit Beckerman, Guy Haber, David Varon, Arie Ben-Yehuda, Mordechai Muszkat

Original Research Article

Modulation of Human Peripheral Blood Mononuclear Cell Proliferative Response by Diltiazem

Antonella D’Ambrosio, Luciana Giordani, Manuela Colucci, Nicola Vanacore, Francesca Quintieri

Dec 08
Issue: 12/2008
Feb 09
Issue: 2/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits